Alpha-1 AD Carriers and Lung Cancer Risk
Tab Title Description
Describes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
- Rochester, Minnesota: 221-98
Sponsor Protocol Number: 221-98
About this study
The purpose of this study is to collect medical and family histories, blood and/or tumor tissue samples from patients who are being tested for or who have or had lung cancer. This study will help us to develop better ways to screen people at risk for lung cancer and develop better treatments for patients diagnosed with lung cancer. This study will also help us to learn whether certain genes (inherited factors from your parents) increase the risk of developing lung cancer.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
- All primary lung cancer cases diagnosed between 2005 and 2009 who are ≥ 50 years of age and smoked cumulatively 20 pack-years or more of cigarettes
- If a former smoker, stopped smoking within 10 years prior to diagnosis
- All Olmsted County residents diagnosed with primary lung cancer during 1997-2009 (approximately 400) will be included to continue our special emphasis of population-based analyses. (Note: 200 cases may overlap between the two groups.)
- Patients who do not speak English
- From outside of Midwest region (MN, WI, IA, ND, SD, NE, KS, MO, IL, MI, IN, and OH)
- Are non-U.S. citizens or residents
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
|Mayo Clinic Location
Mayo Clinic principal investigator
Ping Yang, M.D., Ph.D.
Closed for enrollment
Cancer Center Clinical Trials Referral Office
Publications are currently not available
Study Results Summary
Not yet available
Supplemental Study Information
Not yet available